#38 Innovation at the Helm: Christina Nesheva’s Vision for mRNA Medicines and Strategic Impact
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
#38 Innovation at the Helm: Christina Nesheva’s Vision for mRNA Medicines and Strategic Impact
-
Narrated by:
-
By:
About this listen
In this episode, we sit down with Christina Nesheva, a seasoned leader at the nexus of strategy and commercialization in biotech, life sciences, and deep tech. With a proven track record of aligning R&D roadmaps with pivotal value inflection points and crafting optimal commercialization strategies, Christina has been instrumental in driving innovation across these high-impact sectors. Currently, as Chair of the Board at Officinae Bio, a pioneering biotech company focused on optimizing mRNA medicines, she spearheads strategy development, strategic partnerships, and fundraising efforts. Christina also advises an early-stage biotech VC fund and several startups, bringing her expertise to the forefront of biotech and deep tech innovation. Tune in for an exciting episode that speaks about innovation, the functioning of the deep tech world, and necessary mindsets for success no matter what industry you're working in.